Marc Tessier-Lavigne

REGN

Marc Tessier-Lavigne serves as Director at Regeneron Pharmaceuticals, Inc. (REGN). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

17 trades

$57.47M

Net Position

Net Seller

$57.47M

Companies Traded

DNLI, REGN

Active Period

Mar 2021 – Nov 2022

17 total trades

Most Recent

Sell DNLI

Nov 28, 2022 · $609.6K

Marc Tessier-Lavigne's Insider Trading at Regeneron Pharmaceuticals, Inc. (REGN)

Buys

0 · $0.00

Sells

5 · $31.71M

Total Shares Bought

Total Shares Sold

47,002

REGN Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Oct 3, 2022	Sell	10,838	$702.24	$7.61M	6,051
Mar 23, 2022	Sell	7,439	$690.00	$5.13M	2,269
Mar 18, 2022	Sell	12,191	$678.21	$8.27M	2,269
Dec 10, 2021	Sell	3,784	$665.00	$2.52M	2,078
Sep 15, 2021	Sell	12,750	$641.71	$8.18M	14,012

Marc Tessier-Lavigne's Insider Trading at Denali Therapeutics Inc. (DNLI)

Buys

0 · $0.00

Sells

12 · $25.76M

Total Shares Bought

Total Shares Sold

477,509

DNLI Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 28, 2022	Sell	20,000	$30.48	$609.6K	1,870,356
Nov 3, 2022	Sell	20,000	$30.27	$605.5K	1,901,608
Sep 30, 2022	Sell	20,000	$30.82	$616.3K	1,914,779
Aug 25, 2022	Sell	20,000	$31.61	$632.3K	1,930,456
Jul 27, 2022	Sell	20,000	$35.61	$712.1K	1,950,556
Mar 25, 2022	Sell	20,000	$33.83	$676.6K	2,035,968
Dec 30, 2021	Sell	63,131	$44.43	$2.81M	96,398
Jun 8, 2021	Sell	94,378	$70.35	$6.64M	2,545,070
May 24, 2021	Sell	46,763	$60.11	$2.81M	2,551,102
May 5, 2021	Sell	3,237	$60.11	$194.6K	2,589,157
Apr 5, 2021	Sell	50,000	$56.62	$2.83M	2,628,073
Mar 3, 2021	Sell	100,000	$66.22	$6.62M	2,723,526